Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Instagram X-twitter Linkedin-in Youtube
GET IN TOUCH

1inhaler

1inhaler makes a breath-activated, single-dose inhaler the size of a credit card
2017
Edinburgh, United Kingdom

https://www.1nhaler.com/

Consumer HealthcareDrug Delivery and DevicesHealthcare Packaging
  • Consumer Healthcare
  • Drug Delivery and Devices
  • Healthcare Packaging
Innovation
Investment Funding
People
About
Products
Future Plan
M&A and Collabs
News

Innovation

Industry Problem

Many dry-powder inhalers are bulky, multi-component or difficult to use for single-dose emergency and specialty medicines.

R&D Focus

Single-dose dry-powder inhalers, breath activation and drug-device combinations.

Innovative Solution

A thin, credit-card-sized inhaler uses a protected membrane and airflow design to disperse one preloaded powder dose when the patient inhales.

Solution Effectiveness

The company reports performance comparable with leading multidose dry-powder inhalers and completion of clinical proof-of-concept work.

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

$2.54 M

Last Funding Amount

$2.56 M

Last Funding Date

11/27/2023

Startup Stage

Early Stage

Lead Investors

Archangels, British Business Investments, Dr Yusuf Hamied

People

Founders

  • Don Smith
  • Lisa McMyn

CEO

  • Lisa McMyn

About

1inhaler makes a breath-activated, single-dose inhaler the size of a credit card

Products

Product

1nhaler single-dose dry-powder inhaler platform.

Star Product

1nhaler device, because its thin single-dose format is the company’s core product and licensing platform.

Future Plan

Market Expansion

Targeting pharmaceutical partners for respiratory, emergency and specialty medicines.

Investment Funding

Announced £1.5 million in new funding for the next growth phase; earlier support included a £2 million round and a £765,000 Scottish Enterprise grant.

M&A and Collabs

Collab

Pharmaceutical companies: drug-device combination development and licensing programs.

Collab

Scottish Enterprise: development funding and commercialization support.

Something missing or incorrect on this page? Help us enrich this information

Claim Now and Contribute